AAQ.DE 1.235 -0.005 0.00% ATEC 5.70 +0.42 +7.37% ARTC.PK 0.00 N/A 0.00% BMTI 12.09 -0.06 0.00% CDNGF.PK 2.40 0.00 0.00% CNMD 23.365 +0.035 +0.15% CRG.L 63.76 +4.76 +7.47% CUR.DE 3.43 +0.066 +1.92% EXAC 19.87 +0.03 +0.15% IIN.L 0.70 +0.00 0.00% JPMBF.PK 5.90 0.00 0.00% MAKO 13.64 +0.13 +0.95% NUVA 42.60 +0.23 +0.54% OFIX 35.44 -0.02 0.00% VITA 4.04 -0.16 0.00% OSTE 3.97 -0.12 0.00% RGBO.OB 0.00 N/A 0.00% RTIX 4.11 -0.01 0.00% SNN 51.89 -0.11 0.00% SYK 54.9225 -0.0775 0.00% SMA 9.26 -0.07 0.00% SYST.VX 130.90 -0.60 0.00% TIG.BR 3.97 +0.27 +6.80% TSON 4.06 +0.01 +0.25% WMGI 16.75 -0.34 0.00% ZMH 58.73 -0.38 0.00% as of: 09:01 ET, delayed quotes
9:30 a.m. RTI Biologics launched BTB Select®, an allograft that provides precision-sized tendons for anterior cruciate ligament reconstruction, and BioCAP Select™, a composite allograft plug for
customized bone void filling. (Source: RTI Biologics Inc.)
DePuy Orthopaedics has reportedly sent a letter to doctors, stating that recently-analyzed data from Australia suggested that the ASR, a metal-on-metal hip implant, has a higher than expected failure rate when used in traditional hip replacement in certain patient types. (Source: New York Times)
Healthcare of Today signed a letter of intent with DyfucaMed, maker of the DyfucaMed® Ratio Applicator for performing Autogenous Hematopoetic Tissue Grafts. The device delivers controlled application of a concentrated platelet
gel that may accelerate tissue regeneration, reduce pain and prevent infection in a variety of procedures, including hip replacement. (Source: Healthcare of Today)
8:00 a.m. Integra LifeScience released the Integra™ Total Wrist Fusion System, designed to provide fixation of the wrist while decreasing
soft tissue irritation. (Source: Integra LifeSciences Holdings Corporation)
Integra LifeSciences introduced Mozaik™ Moldable Morsels bone void filler, available in 4 sizes to fill voids or gaps in the extremities, spine and
pelvis. (Source: Integra LifeSciences Holdings Corporation)
Study results indicate that non-invasive Extracorporeal Shock Wave Technology, applied with SANUWAVE’s Ossatron® device followed by fracture
immobilization, resulted in an 80% rate of healing of nonunion tibial fractures. In 2Q10, the company will introduce the orthoPACE™ device to replace the Ossatron. orthoPACE will be indicated for a range of orthopaedic, sports medicine and trauma indications. (Source: SANUWAVE Health, Inc.)
Smith & Nephew Endoscopy launched the BIORAPTOR™ Knotless Suture Anchor for the repair of torn labrum in
the hip and shoulder. (Source: Smith & Nephew, Inc.)
|